EDN1 and interstitial lung disease: Increased ET-1 expression has been demonstrated in the lungs of patients with IPF [52], pulmonary fibrosis with PH [53], systemic sclerosis-ILD (SSc-ILD) [54] and the serum of patients with IPF and CTD-ILD [55].